In contrast, using the same platform, HDAC2, 3 and 8 were presented with a proclivity towards tumor-dependent augmented transcription, thus indicating the differential contribution of each HDAC enzyme to bladder cancer development [165,171]. The gene discussed is HDAC2; the disease is urinary bladder carcinoma.